Update on antifungal agents for paediatric patients : Invasive fungal infections in paediatric patientsGROLL, A. H; TRAGIANNIDIS, A.Clinical microbiology and infection. 2010, Vol 16, Num 9, pp 1343-1353, issn 1198-743X, 11 p.Article

Antifungal agents: In vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy : Antimicrobial pharmacokinetics and pharmacodynamics for the clinicianGROLL, A. H; KOLVE, H.European journal of clinical microbiology & infectious diseases (Print). 2004, Vol 23, Num 4, pp 256-270, issn 0934-9723, 15 p.Article

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. epidemiology, management and long-term survivalGROLL, A. H; KURZ, M; SCHNEIDER, W et al.Mycoses. 1999, Vol 42, Num 7-8, pp 431-442, issn 0933-7407Article

Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbitsPETRAITIS, V; PETRAITIENE, R; GROLL, A. H et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 11, pp 2898-2905, issn 0066-4804Article

Fortschritte in Prävention und Therapie infektiöser Komplikationen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Advances in prevention and treatment of infectious complications in children and adolescents with cancerGROLL, A. H; MÜLLER, F.-M. C.Klinische Pädiatrie. 1998, Vol 210, Num 3, pp 106-114, issn 0300-8630Article

Uncommon opportunistic fungi : new nosocomial threatsGROLL, A. H; WALSH, T. J.Clinical microbiology and infection. Supplement. 2001, Vol 7, Num 2, pp 8-24, issn 1470-9465Article

AIDS-associated atypical Pneumocystis carinii pneumonia revisitedGROLL, A. H; KEUL, H.-G; BRODT, R et al.Clinical infectious diseases. 1998, Vol 26, Num 4, pp 1005-1006, issn 1058-4838Article

Invasive pulmonary aspergillosis in a critically III neonate : Case report and review of invasive aspergillosis during the first 3 months of lifeGROLL, A. H; JAEGER, G; ALLENDORF, A et al.Clinical infectious diseases. 1998, Vol 27, Num 3, pp 437-452, issn 1058-4838Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseasesULLMANN, A. J; CORNELY, O. A; GARBINO, J et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 1-8, issn 1470-9465, 8 p.Article

Phase II Dose Escalation Study of Caspofungin for Invasive AspergillosisCOMELY, O. A; VEHRESCHILD, J. J; HARNISCHMACHER, U et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5798-5803, issn 0066-4804, 6 p.Article

Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCTMASJOSTHUSMANN, K; EHLERT, K; EING, B. R et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 9, pp 679-684, issn 0268-3369, 6 p.Article

Trimethoprim-sulfamethoxazole salvage for refractory listeriosis during maintenance chemotherapy for acute lymphoblastic leukemiaWACKER, P; OZSAHIN, H; GROLL, A. H et al.Journal of pediatric hematology/oncology. 2000, Vol 22, Num 4, pp 340-343, issn 1077-4114Conference Paper

Interleukin 6 as early mediator in neonatal sepsisGROLL, A. H; MEISER, A; WEISE, M et al.The Pediatric infectious disease journal. 1992, Vol 11, Num 6, pp 496-498, issn 0891-3668Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDSLORTHOLARY, O; PETRIKKOS, G; CUENCA-ESTRELLA, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 68-77, issn 1470-9465, 10 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida sppHOPE, W. W; CASTAGNOLA, E; CUENCA-ESTRELLA, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 38-52, issn 1470-9465, 15 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)ULLMANN, A. J; AKOVA, M; CORNELY, O. A et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 53-67, issn 1470-9465, 15 p.Article

Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosisTRAGIANNIDIS, A; GROLL, A. H.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 5, pp 82-86, issn 1470-9465, 5 p.Conference Paper

Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbitsPETRAITIENE, R; PETRAITIS, V; GROLL, A. H et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 9, pp 2148-2155, issn 0066-4804Article

Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbitsGROLL, A. H; SEIN, T; PETRAITIS, V et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 10, pp 2700-2705, issn 0066-4804Article

Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalGROLL, A. H; SHAH, P. M; MENTZEL, C et al.The Journal of infection. 1996, Vol 33, Num 1, pp 23-32, issn 0163-4453Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: diagnostic proceduresCUENCA-ESTRELLA, M; VERWEIJ, P. E; BASSETTI, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 9-18, issn 1470-9465, 10 p.Article

Trends in the postmortem epidemiology of invasive fungal infections at a university hospitalLEHRNBECHER, T; FRANK, C; ENGELS, K et al.The Journal of infection. 2010, Vol 61, Num 3, pp 259-265, issn 0163-4453, 7 p.Article

Empfehlungen zur Prävention der Pneumocystis-carinii-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancerGROLL, A. H; RITTER, J; MÜLLER, F.-M. C et al.Klinische Pädiatrie. 2001, Vol 213, pp A38-A49, issn 0300-8630, SUP1Article

Prävention von Pilzinfektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen = Prevention of fungal infections in children and adolescents with cancerGROLL, A. H; RITTER, J; MÜLLER, F.-M. C et al.Klinische Pädiatrie. 2001, Vol 213, pp A50-A68, issn 0300-8630, SUP1Article

Esophageal candidiasis in pediatric acquired immunodeficiency syndrome : clinical manifestations and risk factorsCHIOU, C. C; GROLL, A. H; GONZALEZ, C. E et al.The Pediatric infectious disease journal. 2000, Vol 19, Num 8, pp 729-734, issn 0891-3668Article